Peak Pharmaceuticals (OTCMKTS:PKPH) Stock Price Down 16% – Time to Sell?

Peak Pharmaceuticals, Inc. (OTCMKTS:PKPHGet Free Report)’s stock price traded down 16% during trading on Friday . The stock traded as low as $4.20 and last traded at $4.20. 1,483 shares changed hands during trading, a decline of 84% from the average session volume of 9,053 shares. The stock had previously closed at $5.00.

Peak Pharmaceuticals Price Performance

The business has a fifty day moving average of $1.92 and a 200-day moving average of $1.86.

Peak Pharmaceuticals Company Profile

(Get Free Report)

Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.

Read More

Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.